Skip to main content
. Author manuscript; available in PMC: 2016 Jan 26.
Published in final edited form as: Acad Pediatr. 2012 May 8;12(4):269–282. doi: 10.1016/j.acap.2012.02.004

Table 2.

Interventions to improve screening and follow-up of abnormal screening tests in pediatric primary care, by type of study design

Author, year, design Condition(s) being screened and screening test(s) Pre-Intervention or control group screening (%of patients screened, unless otherwise specified) Post-Intervention or experimental group screening (% of patients screened, unless otherwise specified) Significance testing (p-value unless otherwise specified) Nature of the intervention, setting/population, and other comments about the study
Randomized Controlled Trials
1. Margolis PA, et al. (2004) RCT20 Lead poisoning, anemia, and tuberculosis:

Serum lead level:
Intervention
Control
23%
18%
68%
30%
<0.05 Intervention: Process improvement methods (aka “knowledge translation”) to improve office systems around preventive care services.
  • Formation of practice-based improvement teams

  • Ongoing academic detailing by project staff

  • Plan-do-study-act cycles with goal setting, workflow mapping, audit/feedback.

Setting/population: 44 practices in North Carolina were randomized to intervention vs. usual care; n=~660 each for post-intervention control and experimental groups; children aged 24–30 months.
Other comments: Data were collected pre- and post-intervention for both control and experimental group practices. Tuberculosis screening was PPD, Mantoux test, or risk assessment
Hematocrit:
Intervention
Control
65%
64%
79%
71%
<0.05
Tuberculosis screening:
Intervention
Control
34%
30%
54%
32%
<0.05
2. Minkovitz CS, et al. (2003) RCT35 Developmental problems:

Parent-reported developmental assessment
41–43% 82–84% <0.001 Intervention: Healthy Steps (HS) program
a. Co-located developmental specialists to enhance well-child visits; also conducted home visits, provided telephone information line for parents about development, written materials, parent groups, linkages to community resources
Setting/population: 15 practices randomized in 14 states; experimental n=2021 patients, control n=1716 patients; post-intervention data were collected for children aged 30–33 months.
Other comments: Parents reported any developmental screening questions (not specifically whether a formal tool was used)
3. Scholes D, et al. (2006) RCT27 Chlamydia infection:

Urine Chlamydia screening
Practice-level intervention: 37.5% 39.6% 0.31 Intervention: Practice and patient-level interventions
  • Practice-level intervention—Use of peer opinion leader teams; 1 day training session around implementing screening guidelines; quarterly feedback reports on screening quality

  • Patient level intervention--EMR point-of-care reminder to screen sexually-active adolescent females

Setting/population: 23 practices in Washington state; experimental n=3511 patients, control n=3649 patients; females aged 14–20 years.
EMR reminder: 40.8% 42.6% 0.27
4. Shafer MA, et al. (2002) RCT23 Chlamydia infection:

Urine Chlamydia screening
21% 65% <0.001 Intervention: Quality improvement initiative within managed care network
  • Practices formed improvement teams; monthly meetings to strategize about solutions to self-identified barriers to screening, using Plan-Do-Study-Act cycles; performance monitoring

  • Intervention targeted preventive care visits

Setting/population: 10 pediatric practices in California; experimental n=1017 patients, control n=1194 patients; sexually active adolescent females.
5. Tebb KP, et al. (2009) RCT29 Chlamydia infection:

Urine Chlamydia screening
Intervention
Control
26%
32%
42%
30%
<0.001 Intervention: Quality improvement initiative within managed care network
  • Practices formed improvement teams; monthly meetings with focus on workflow, performance monitoring using Plan-Do-Study-Act cycles

  • Intervention targeted urgent care visits

Setting/population: 10 pediatric practices in California; n was not reported; sexually active adolescent females
Other comments: Data were collected pre- and post-intervention for both control and experimental group practices.
Pre-post intervention design
6. Adams WG et al. (2003) Pre-post37 Developmental problems, anemia, lead poisoning, hearing and vision problems:

Language development
65.1% 70.0% Relative risk (95% confidence interval):

1.07 (0.97–1.09)
Intervention: EMR template with prompts to improve preventive care services
  • Prompts included were age-specific milestones regarding development in social, fine/gross motor, and language skills, with checkboxes and normal ranges.

  • Other prompts were for anticipatory guidance and screening for psychosocial problems.

Setting/population: One practice in Massachusetts with >28,000 visits/year; pre-intervention n=235 patients; post-intervention n=986 patients; children aged 0–5 years
Other comments: Pre-intervention group had paper charts with well-child visit templates; sample for specific tests varied because some tests are recommended only for a subset based on age.
Behavior/social development 26.4% 65.7% 1.16 (1.04–1.28)
Motor development 63.8% 73.9% 2.49 (2.00–3.10)
Hematocrit 82.5% 85.3% 1.03 (0.91–1.17)
Serum lead level 66.7% 79.1% 1.19 (0.99–1.43)
Vision 42.9% 50.0% 1.17 (0.80–1.70)
Hearing 33.3% 48.3% 1.45 (0.92–2.28)
7. Applegate H, et al. (2003) Pre-post33 Behavior, developmental and emotional problems:

Discussion about behavior, developmental or emotional problems (# items discussed per visit)
1.6 items 10.4 items per visit after Stage 1; 9.9 items per visit after Stage 2 Intervention: Provider education and support tools to implement Pediatric Symptom Checklist (PSC); intervention was 2 stages
  • Stage 1: Provider training session about screening tool, importance of screening, screener placed on medical chart

  • Stage 2: Implementation of provider and patient handouts that followed the structure of the PSC and were designed to address specific subgroups of symptoms.

Setting/population: One academic pediatric practice; pre-intervention n=16 patients; post-intervention n=38 patients; children aged 6–16 years.
Other comments: No significance testing reported
Intervention for behavior and emotional problems (# of interventions per visit) 0 interventions 0.125 interventions per visit after Stage 1; 1.9 interventions per visit after Stage 2
8. Block B, et al. (1996) Pre-post40 Follow up of elevated lead levels:

Follow up plan in chart
32% 100% Intervention: Nurse-led protocol to follow up abnormally elevated lead levels--
  • Case management performed by a nurse

  • Nurse-initiated physician education on specific cases

  • Electronic tracking of patients within the practice

  • Joint tracking of patients with public health department

Setting/population: One academic family medicine practice in Pennsylvania; pre intervention n=22 patients with abnormal lead levels, post intervention n=99 patients with abnormal lead levels
Other comments: No significance testing reported
Follow up serum lead level done 9% 65%
Parent education about reducing exposure, if persistently high levels Not measured 28%
9. Bordley WC, et al. (2001) Pre-post22 Anemia, lead poisoning, tuberculosis:

Hematocrit
45% 67% 0.001 Intervention: Quality improvement intervention to improve preventive care:
  • Practice improvement teams

  • Specific changes to workflow were individualized by practices and included:

  • Sending patient reminder cards

  • Chart screening prior to patient being seen

  • Chart flagging

  • Using flowsheets and medical record templates

Setting/population: 8 practices in North Carolina, pre-intervention n=339 patients; post-intervention n=300; children aged 24–30 months
Other comments: Lead and tuberculosis screening was risk assessment and laboratory/skin testing, if indicated
Lead screening 12% 48% 0.001
Tuberculosis screening 50% 52% NS
10. Dunlop AL, et al. (2007) Pre-post32 Obesity:

BMI percentile documented in chart
12% 15% after Stage 1
28% after Stage 2
NS
<0.05
Intervention: Provider training and support tools for obesity. 2 staged intervention:
  • Stage 1: 2-hour provider training explaining guidelines for assessing and managing overweight and counseling framework (AIM--Advise, Identify, Motivate); training on using BMI calculator and growth charts

  • Stage 2: 3 month supply of tools--parent screening tool/counseling guide, BMI charts, “prescription pad” for nutrition/physical activity

Population/setting: 6 academic family medicine and pediatric practices in Georgia; pre-intervention n=466; Stage 1 n=538, Stage 2 n=344; children aged 2–17 years
Nutrition and activity history 50% 56% after Stage 1
81% after Stage 2
NS
<0.05
Nutrition and activity counseling 33% 35% after Stage 1
47% after Stage 2
NS
<0.05
11. Lannon CM, et al. (2008) Pre-post21 Developmental problems

PEDS or ASQ
30% (received any developmental screening) 45% (using structured tool (e.g., ASQ)) NS Intervention: Bright Futures Training Intervention Project: learning collaborative/quality improvement initiative to improve preventive care services
  • Key practice-level changes included:

    • Structured developmental screening (PEDS or ASQ)

    • Chart prompts

    • Patient recall/reminder

    • Linkages with community agencies

  • Used practice improvement teams and plan-do-study-act cycles

Population/setting: 15 practices in 9 states; experimental n=305 patients, control n=171 patients; children aged 0–5 years
Other comments: No participating practices used formal developmental screening tools pre-intervention.
12. Polacsek M, et al. (2009) Pre-post25 Obesity:
BMI documented in chart

Screening with previsit, self-administered tool to assess patient’s behavior around nutrition and physical activity
38%

Not measured
94%

82%
<0.001

<0.001
Intervention: Learning collaborative
  • Teams of physician, nurse and administrator from each practice; 3 1.5 day learning sessions for teams; practices set goals around nutrition and physical activity screening and counseling.

  • Patient screening instruments and provider decision support tools for obesity management

Population/setting: 12 practices in Maine; n=600 patients with visits during both pre and post intervention periods; children aged 5–18 years.
13. Shaw JS, et al. (2006) Pre-post19 Lead poisoning, anemia, tuberculosis, hypertension:

Lead screening
72% 85% 0.001 Interventions: State-wide learning collaborative with 4 1-day learning sessions
  • Practices formed teams (physician, nurse, administrator) and chose preventive care outcomes to address through practice improvements.

  • Included periodic statewide gatherings for QI training, collaborative telephone calls, audit/feedback to practices

Population/setting: 31 practices in Vermont; pre- and post-intervention n= each approx 930 patients; children aged 2–4 years
Other comments: Tuberculosis and lead screening were risk assessment and laboratory/skin testing, if indicated.
Hematocrit 70% 74% NS
Vision screening 62% 75% 0.013
Tuberculosis screening 18% 39% 0.001
Blood pressure 85% 82% NS
14. Young PC, et al. (2006) Pre-post18 Anemia, vision problems, hypertension, obesity:

Hematocrit
49% 57% 0.36 Intervention: Learning collaborative
  • Practices chose aspects of preventive care to focus improvement efforts. Included QI methodology training, conference calls with participating practices, and chart audit/feedback

Population/setting: 14 practices in Utah; pre-intervention n=544 patients; post-intervention n=517 patients; children aged 2–4 years
Vision screening 46% 75% 0.007
BP screening 59% 74% 0.010
BMI recorded 32% 45% 0.078
Post intervention with and without a control group
15. Gioia PC. (2001) Post intervention without control group38 Lead poisoning:

Serum lead level
Not measured 81% Intervention: EMR with point-of-care reminders displayed on screen
Population/setting: Single practice in New York; n=208 patients; children born in 1998
16. Hartmann EE, et al. (2006) Post-intervention without control group34 Vision disorders: monocular visual acuity and stereopsis

3 year olds
Not measured 70–85% Intervention: Vision screening with specific tools for assessing monocular visual acuity and stereopsis.
  • Provided written guidelines for referral, follow-up based on screening results.

  • Physician and staff training, either in group sessions or one-on-one training Initiative included both Head Start and primary care practices

Population/setting: 28 practices in Ohio and Tennessee; n=627 patients; children aged 3–4 years.
4 year olds Not measured 93–94%
17. Hull PC, et al. (2008) Post-intervention with concurrent control group39 Lead poisoning, anemia, hearing, vision:

“Laboratory testing” (serum lead level and hematocrit)
74% 100% <0.001 Intervention: Nurse-led protocol
  • EPSDT screening, carried out by a nurse with a specific preventive care role, using protocol attached to medical record.

Population/setting: One academic practice received intervention; control group was sample of children from other practices. Intervention group n=514, control n=115 patients; children aged 0–17 years
Hearing 12% 100% <0.001
Vision 23% 100% <0.001
18. Niederman LG, et al. (2007) Post-intervention with concurrent control group36 Anemia and lead poisoning:
Hematocrit
77% 73% NS Intervention: Healthy Steps (HS) program implemented in a resident continuity clinic.
Population/setting: One academic practice in Illinois; experimental n=71, control n=192 patients; children aged at least 18 months
Other comments: Control group were patients in the practice but not enrolled in HS
Serum lead level 64% 67% NS
19. Ozer EM, et al. (2005) Post-intervention with concurrent control group31 Adolescent health risk behaviors:

Adolescent health screening questionnaire
Not measured 80% NA Intervention: Provider training, patient questionnaire, and prompts to facilitate communication about adolescent risk behaviors 2 stage intervention:
  • Stage 1: 8-hour provider training workshop around knowledge and skills regarding adolescent preventive care

  • Stage 2: Introduction of patient questionnaire and provider form to screen for and document discussion and counseling regarding risky behaviors.

Population/setting: 4 practices in California (2 practices received the intervention); experimental n=1717, control n=911 patients; adolescents aged 14–17 years
Other comments: Control practices’ screening did not differ over study period
Provider asked about alcohol use during visit 67% 82% after Stage 1
83% after Stage 2
<0.01
<0.001
Provider counseled on alcohol use during visit 59% 77% after Stage 1
81% after Stage 2
<0.01
<0.001
20. Schonwald A, et al. (2009) Post intervention without cuncurrent control group30 Behavior and development problems:

PEDS
Not measured 61% Intervention: Implementation of developmental screening using PEDS
  • 1-hour provider and staff training; physician champion who was available to answer questions from providers and staff.

  • Offered as option for referral a second-stage screening service at the practice staffed by an educational specialist

Population/setting: 1 practice in Massachusetts; pre-intervention n=338 patients, post-intervention n=278 patients; children aged 20–40 months
Other comments: Use of structured developmental assessments was not routine pre-intervention; authors reported an increase in developmental concerns identified post-intervention (21% vs. 26%, p=0.05); proportion of children referred for developmental concerns did not change post intervention (10% vs 11%).
Time Series
21. Earls M, et al. (2006) Time series28 Developmental problems:
ASQ
24% 62% at year 2; 76% at year 5 Intervention: Quality improvement initiative to improve child development services:
  • Practices completed Plan-Do-Study-Act cycles

  • Emphasized physician champion, workflow map, staff involvement, and periodic data review

  • Part of a larger state-wide initiative that involved state-level policy changes around child developmental services

Population/setting: Several practices in North Carolina; sample size was not reported
Other comments: No significance testing reported
22. King TM, et al. (2010) Time series24 Development problems:
PEDS or ASQ
Not measured 67% at 1 month; 85% at 9 months Intervention: Provider and staff education, physician champion identification
  • One-day workshop for practice teams. Practices teams were a group of three key stakeholders within each practice (physician champion, staff member, and another person).

  • AAP-sponsored national pilot project to implement guideline-adherent developmental screening

Population/setting: 17 practices from 15 states; pre- and post-intervention n≈1020 children total; children aged 8–36 months
Other comments: Post-intervention screening varied among practices (33–100%); no significance testing reported
23. Pomietto M, et al. (2009) Time series26 Obesity:
BMI and weight classification documented in chart
Not measured 49% at 1 month; 94% at 9 months Intervention: Learning collaborative, combined with community and policy-level interventions.
  • Practices participated in 3 8-hour training sessions, monthly phone calls, and practice-based coaching in QI, which included on-site visits to practices

  • Coincided with community-level efforts to better manage chronic conditions, including obesity

Population/setting: 8 practices in Washington state. Chart audits of 20 pediatric patients per month per practice were tracked for 9 months. Age range of patients was not reported.
Other comments: No significance testing reported

Abbreviations:

HS – Healthy Steps

LC – Learning collaborative

BMI – Body mass index

BP – Blood pressure

QI – Quality improvement

HMO – Health maintenance organization

PEDS – Parents’ evaluation of developmental status

EMR – Electronic medical record

EPSDT – Early periodic screening, diagnosis and treatment

ASQ – Ages and stages questionnaire

AAP – American Academy of Pediatrics

RCT – Randomized controlled trial